Can Pfizer's and Moderna's COVID-19 Vaccine Sales Double Next Year?
Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) expect their COVID-19 vaccine will generate sales of $33.5 billion this year. Moderna (NASDAQ: MRNA) anticipates sales of around $20 billion this year for its vaccine. But there are some new estimates out that project those sales figures could soar in 2022 -- and even nearly double for one of the vaccines. In this Motley Fool Live video recorded on Oct. 20, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not these new projections are realistic.
Source Fool.com
